Form D · Biotechnology
Aligos Therapeutics, Inc.
South San Francisco, CA · CIK 0001799448
Offering snapshot reported Feb 28, 2025 · SEC filing
- Reported sold
- $105M Offering amount: $105M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 11, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 28, 2025 | Initial | $105,003,206 | No comparison | 12 | SEC filing |
| Nov 7, 2023 | Initial | $92,150,000 | No comparison | 11 | SEC filing |
| Jan 16, 2020 | Initial | $85,000,001 | No comparison | 38 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $2.7M
- Finders' fees
- $0
- Form D file number
- 021-539576
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Jefferies LLC | None | |
| Piper Sandler & Co. | None |
Source: Form D, filed Feb 28, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Hardean Achneck | Executive |
| Leonid Beigelman | Director, Executive |
| Lawrence M. Blatt | Director, Executive |
| Lesley Ann Calhoun | Executive |
| Sushmita Chanda | Executive |
| Margarita Chavez | Director |
| Brian Dowd | Executive |
| John Fry | Executive |
| Kathleen Glaub | Director |
| Peter Hirth | Director |
| K. Peter Hirth | Director |
| Bridget Martell | Director |
| Matthew Mc Clure | Executive |
| Peter Moldt | Director |
| Carole Neuchterlein | Director |
| Jack Nielsen | Director |
| Carole Nuechterlein | Director |
| Heather Preston | Director |
| Lucinda Quan | Executive |
| James Scopa | Director |
| Julian Symons | Executive |
| Tom Woiwode | Director |
| Michael Yi | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
One Corporate Dr., 2nd Floor
South San Francisco, CA, 94080
South San Francisco, CA, 94080